drugset / Trial / NCT00003241

Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors

NCT00003241 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of phenylacetate in treating children with recurrent or progressive brain tumors.

Timeline

Start
1998-05
Primary completion
—
Completion
2004-09

Drugs

EvaluationDrugModalityDoseRoute
Subject phenylacetate Unknown — Intravenous